Biocompatible adipose extracellular matrix and reduced graphene oxide nanocomposite for tissue engineering applications

• Published in: Materials today bio 2024-06, Vol.26, p.101059-101059, Article 101059
• Main Authors: Verstappen, Kest, Klymov, Alexey, Cicuéndez, Mónica, da Silva, Daniela M., Barroca, Nathalie, Fernández-San-Argimiro, Francisco-Javier, Madarieta, Iratxe, Casarrubios, Laura, Feito, María José, Diez-Orejas, Rosalía, Ferreira, Rita, Leeuwenburgh, Sander C.G., Portolés, María Teresa, Marques, Paula A.A.P., Walboomers, X. Frank
• Format: Article
• Language: English
• Subjects: Cytotoxicity; Extracellular matrix; Foreign body response; Full Length; Graphene; Macrophages; Nanocomposite
• ISSN: 2590-0064; 2590-0064
• DOI: 10.1016/j.mtbio.2024.101059

Despite the immense need for effective treatment of spinal cord injury (SCI), no successful repair strategy has yet been clinically implemented. Multifunctional biomaterials, based on porcine adipose tissue-derived extracellular matrix (adECM) and reduced graphene oxide (rGO), were recently shown to stimulate in vitro neural stem cell growth and differentiation. Nevertheless, their functional performance in clinically more relevant in vivo conditions remains largely unknown. Before clinical application of these adECM-rGO nanocomposites can be considered, a rigorous assessment of the cytotoxicity and biocompatibility of these biomaterials is required. For instance, xenogeneic adECM scaffolds could still harbour potential immunogenicity following decellularization. In addition, the toxicity of rGO has been studied before, yet often in experimental settings that do not bear relevance to regenerative medicine. Therefore, the present study aimed to assess both the in vitro as well as in vivo safety of adECM and adECM-rGO scaffolds. First, pulmonary, renal and hepato-cytotoxicity as well as macrophage polarization studies showed that scaffolds were benign invitro. Then, a laminectomy was performed at the 10th thoracic vertebra, and scaffolds were implanted directly contacting the spinal cord. For a total duration of 6 weeks, animal welfare was not negatively affected. Histological analysis demonstrated the degradation of adECM scaffolds and subsequent tissue remodeling. Graphene-based scaffolds showed a very limited fibrous encapsulation, while rGO sheets were engulfed by foreign body giant cells. Furthermore, all scaffolds were infiltrated by macrophages, which were largely polarized towards a pro-regenerative phenotype. Lastly, organ-specific histopathology and biochemical analysis of blood did not reveal any adverse effects. In summary, both adECM and adECM-rGO implants were biocompatible upon laminectomy while establishing a pro-regenerative microenvironment, which justifies further research on their therapeutic potential for treatment of SCI. [Display omitted] •Reduced graphene oxide and adipose extracellular matrix scaffolds were synthesized.•Scaffolds did not show cytotoxicity or macrophage polarization in vitro.•Biocompatible, pro-regenerative and angiogenic responses were observed in vivo.•Neither systemic toxicity nor organ-specific inflammation was observed.